2. Academic Validation
  3. TWEAK/Fn14 axis may promote vascular smooth muscle cell senescence via p38 signaling pathway: preliminary evidence

TWEAK/Fn14 axis may promote vascular smooth muscle cell senescence via p38 signaling pathway: preliminary evidence

  • Future Sci OA. 2025 Dec;11(1):2455906. doi: 10.1080/20565623.2025.2455906.
Chunyang Wei 1,  Xiaoying Liu 1,  Zhuang Miao 2,  Hua Zhang 1,  Yanfu Wang 1,  Guoxian Qi 3
Affiliations

Affiliations

  • 1 Department of Gerontology, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • 2 Department of Anesthesiology, the First Affiliated Hospital, Dalian Medical University, Dalian, China.
  • 3 Department of Gerontology, the First Affiliated Hospital, China Medical University, Shenyang, China.
PMID: 39840833 DOI: 10.1080/20565623.2025.2455906
Abstract

Aim: The primary objective of this study is to investigate the impact of tumor necrosis factor-like weak inducer of Apoptosis (TWEAK) and its functional receptor, fibroblast growth factor-inducible 14 (Fn14), on the process of vascular smooth muscle cell (VSMC) senescence.

Methods: Rat arterial VSMCs were cultured with angiotensin II to establish a model of premature senescence. The effects of TWEAK and Fn14 on senescent VSMCs were evaluated. Additionally, the role of p38 phosphorylation pathway in the effect of TWEAK on VSMCs senescence was assessed.

Results: Expressions of TWEAK and Fn14 were significantly elevated in senescent VSMCs. TWEAK activated the p38 phosphorylation pathway and promoted the SA-β-gal staining and P53 expression.

Conclusion: These preliminary findings suggest that the TWEAK/Fn14 axis may play a crucial role in promoting VSMC senescence.

Keywords

Fn14; TWEAK; VSMC; senescence; vascular.

Figures
Products